<DOC>
	<DOCNO>NCT01613469</DOCNO>
	<brief_summary>This study assess complete clinical response ( clinical evidence remain disease recurrence disease ) rectal cancer arise within 3 inch anal opening radiation therapy give time chemotherapy 6 week period , follow chemotherapy alone give three time additional 9 week . Follow-up begin examination end treatment ( 15 week ) , ongoing follow-up every 4-6 week one year .</brief_summary>
	<brief_title>Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy Distal Rectal Cancer</brief_title>
	<detailed_description>Research show low rectal cancer treat neoadjuvant chemoradiation ( 54Gy concurrent 3 cycle 5-FU/Leucovorin ) follow 3 additional cycle 5FU/Leucovorin , follow close follow-up ( every 4-6 week one year ) good success achieve complete clinical response , avoid surgical intervention . If follow-up remain disease find recurrent disease , surgery perform .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>18 year old tumor potentially resectable en bloc ; tumor tether fixed structure remove clinical/radiological stage T2 , T3 , T4 , N01 ANC &gt; 1500 , PLT &gt; 100,000 AST alkaline phosphatase &lt; 2.5 X ULN bilirubin &lt; 1.5 X ULN CrCl &gt; 50 ml/min use CockcroftGault formula KPS &gt; 60 ECOG Performance Scale 02 No malignancy within previous 5 year nonmelanoma skin cancer , insitu cervical cancer , insitu ductal breast cancer evidence metastatic disease initial tumor fixation pelvic bone side wide ; technically unresectable disease evidence distant metastasis perforation obstruction hereditary nonpolyposis colorectal cancer synchronous primary colon carcinoma except T1 lesion know dihydropyrimidine dehydrogenase deficiency prior radiation therapy pelvis prior chemotherapy malignancy know exist uncontrolled coagulopathy pregnancy lactation woman childbearing potential use reliable appropriate contraceptive method serious , uncontrolled concurrent infection ( ) participation investigational drug study within 4 week precede start study treatment clinically significant heart disease serious uncontrolled medical condition might compromise study participation ( investigator 's opinion ) major surgery within 4 week prior study treatment lack physical integrity upper GI tract malabsorption syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>fluorouracil</keyword>
	<keyword>leucovorin</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>neoadjuvant therapy</keyword>
</DOC>